Feedback / Questions
Orladeyo (berotralstat) - BioCryst
https://www.globenewswire.com/news-release/2025/12/12/3204568/29446/en/BioCryst-Announces-FDA-Approval-of-ORLADEYO-berotralstat-Oral-Pellets-First-and-Only-Oral-Prophylactic-Treatment-for-Patients-with-HAE-Aged-2-to-12-Years.html
Dec 12, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next